Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study
A. Schuler, J. Huser, Sabine Schmid, Sämi Schär, Amina Scherz, Oliver Gautschi, Laetitia Mauti, Thomas von Briel, Christine Waibel, Luciano Wannesson, J. Pankovics, Michael Mark, Sacha I. Rothschild, Alfredo Addeo, Wolf-Dieter Janthur, Marco Siano, Laura Amanda Boos, Christian Britschgi, Martin Früh
Topics & Concepts
MedicineOsimertinibLung cancerInternal medicineEpidermal growth factor receptorGastroenterologyOncologyProgressive diseaseIncidence (geometry)CancerErlotinibDiseaseOpticsPhysicsLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis